Pancreatic Cancer Research

ResearcherOregon State UniversityNo recent work listed

Adam W. G. Alani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9214-9317; OpenAlex author ID A5073688663. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment. Co-author DOI 10.3390/pharmaceutics15122651↗
  2. Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics14040713↗
  3. Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer. Last author DOI 10.1016/j.canlet.2020.07.041↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brett C. Sheppard · 3 shared papers, 2020–2023 · strength 0.46
  2. Vidhi M. Shah · 3 shared papers, 2020–2023 · strength 0.46
  3. Rosalie C. Sears · 3 shared papers, 2020–2023 · strength 0.46
  4. Brittany L. Allen-Petersen · 1 shared paper, 2022 · strength 0.15
  5. Motoyuki Tsuda · 1 shared paper, 2023 · strength 0.14
  6. Jonathan Robert Brody · 1 shared paper, 2023 · strength 0.14
  7. Ellen M. Langer · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.